Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Community Health. 2018 Apr;43(2):291–296. doi: 10.1007/s10900-017-0420-x

Table 1.

Respondent characteristics and correlates of reporting a concern about 9-valent HPV vaccine (N=211).

N (%) ≥1 concern
n/N (%) OR (95% CI)
Sex
 Male 13 (6) 4/13 (31) 1
 Female 198 (94) 79/198 (40) 0.67 (0.20–2.24)
Rolea
 Non-clinician 79 (37) 32/79 (39) 1
 Clinician 132 (63) 51/132 (41) 0.92 (0.51–1.69)
Years in role
 ≥10 years 90 (43) 38/90 (42) 1
 5–9 years 55 (26) 22/55 (40) 0.91 (0.46–1.81)
 < 5 years 66 (31) 23/66 (35) 0.73 (0.39–1.37)
Practice location
 Washington 90 (43) 28/90 (31) 1
 Illinois 56 (27) 24/56 (43) 1.67 (0.78–3.52)
 Michigan 65 (31) 31/65 (48) 2.02 (0.87–4.69)
Practice typeb
 Other 99 (47) 37/99 (37) 1
 Private 112 (53) 46/112 (41) 1.17 (0.69–1.97)
Practice specialty
 Family medicine 138 (65) 46/138 (33) 1
 Pediatrics 73 (35) 37/73 (51) 2.06 (1.02–4.15)*
a

Clinician includes physician, nurse, and other vaccine providers. Non-clinician includes office manager, front office staff and other roles.

b

Private practice includes solo, group practice or HMO. Other practice type includes Federally Qualified Health Center, hospital-based clinic, public health department, and military clinic.

*

p<.05